Neuroblastoma, Body Mass Index, and Survival. Issue 14 (April 2015)
- Record Type:
- Journal Article
- Title:
- Neuroblastoma, Body Mass Index, and Survival. Issue 14 (April 2015)
- Main Title:
- Neuroblastoma, Body Mass Index, and Survival
- Authors:
- Small, Annabel G.
Thwe, Le M.
Byrne, Jennifer A.
Lau, Loretta
Chan, Albert
Craig, Maria E.
Cowell, Chris T.
Garnett, Sarah P.
Segura., Miguel F - Abstract:
- <abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Abstract</title> <p>Extremes of body mass index (BMI) at diagnosis of childhood cancers have been associated with poorer prognosis.</p> <p>The aims of this retrospective review were to examine the growth and BMI status of children diagnosed with neuroblastoma (NB) and determine if BMI status at diagnosis affected survival.</p> <p>Between 1985 and 2005, 154 children were diagnosed with NB at Sydney Children's Hospitals Network (Westmead), Australia, of which 129 had both length/height and weight recorded in the medical records at diagnosis. BMI was calculated and children were classified as underweight (BMI &lt;15th percentile), normal weight, and overweight (BMI &gt;85th percentile). Disease stage was classified according to the International NB Staging System.</p> <p>At diagnosis, 24.0% of the children were classified as underweight and 11.6% were overweight. Six months after diagnosis all children except those with stage 4s disease had a decrease in BMI z-score; difference in estimated marginal mean −0.73, <italic>P</italic> &lt; .001. After 12 months an increase in BMI z-score was observed and by 2 years BMI z-score was significantly higher than BMI z-score at baseline; difference in estimated marginal mean 0.81, <italic>P</italic> = .007. At the last follow-up (median 5.6 years [range 3–7] after diagnosis) the proportion of children who were classified as underweight decreased to 8.7% and the<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Abstract</title> <p>Extremes of body mass index (BMI) at diagnosis of childhood cancers have been associated with poorer prognosis.</p> <p>The aims of this retrospective review were to examine the growth and BMI status of children diagnosed with neuroblastoma (NB) and determine if BMI status at diagnosis affected survival.</p> <p>Between 1985 and 2005, 154 children were diagnosed with NB at Sydney Children's Hospitals Network (Westmead), Australia, of which 129 had both length/height and weight recorded in the medical records at diagnosis. BMI was calculated and children were classified as underweight (BMI &lt;15th percentile), normal weight, and overweight (BMI &gt;85th percentile). Disease stage was classified according to the International NB Staging System.</p> <p>At diagnosis, 24.0% of the children were classified as underweight and 11.6% were overweight. Six months after diagnosis all children except those with stage 4s disease had a decrease in BMI z-score; difference in estimated marginal mean −0.73, <italic>P</italic> &lt; .001. After 12 months an increase in BMI z-score was observed and by 2 years BMI z-score was significantly higher than BMI z-score at baseline; difference in estimated marginal mean 0.81, <italic>P</italic> = .007. At the last follow-up (median 5.6 years [range 3–7] after diagnosis) the proportion of children who were classified as underweight decreased to 8.7% and the proportion of children who were classified as overweight increased to 27.5%. The overall survival rate was 61.2%; however, BMI status did not predict survival. In multivariable Cox regression modeling, stage at diagnosis was the only predictor of survival; children diagnosed with stage 4 were less likely to survive (hazard ratio [HR] [95%CI]: 7.02 [1.7–29.0], <italic>P</italic> = .007).</p> <p>Almost a quarter of children with NB were underweight at diagnosis. However, we did not demonstrate a prognostic association between BMI status and survival. The high proportion of children who were classified as overweight at follow-up indicates a need for nutritional interventions to prevent potential late effects.</p> </sec> </abstract> … (more)
- Is Part Of:
- Medicine. Volume 94:Issue 14(2015)
- Journal:
- Medicine
- Issue:
- Volume 94:Issue 14(2015)
- Issue Display:
- Volume 94, Issue 14 (2015)
- Year:
- 2015
- Volume:
- 94
- Issue:
- 14
- Issue Sort Value:
- 2015-0094-0014-0000
- Page Start:
- Page End:
- Publication Date:
- 2015-04
- Subjects:
- Medicine -- Periodicals
Medicine -- Periodicals
Médecine -- Périodiques
Geneeskunde
Medicine
Periodicals
Periodicals
610.5 - Journal URLs:
- http://journals.lww.com/md-journal/pages/default.aspx ↗
http://gateway.ovid.com/ovidweb.cgi?T=JS&PAGE=toc&D=ovft&MODE=ovid&NEWS=N&AN=00002060-000000000-00000 ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/MD.0000000000000713 ↗
- Languages:
- English
- ISSNs:
- 0025-7974
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5534.000000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3989.xml